FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636019019 Extended-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Conventional release oral tablet false Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Is a Modified-release oral tablet true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely clarithromycin (as clarithromycin citrate) 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tapentadol (as tapentadol hydrochloride) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 750 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely ranolazine 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 750 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely conjugated estrogen 625 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely conjugated estrogen 1.25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 37.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 1 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely isosorbide mononitrate 30 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nicotinic acid 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely finasteride 5 milligram and tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely alfuzosin hydrochloride 10 milligram and dutasteride 500 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely zolpidem tartrate 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely piribedil 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.57 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.62 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely metoprolol tartrate (as metoprolol succinate) 12.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely ambroxol acefyllinate 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely aceclofenac 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 133 milligram and valproic acid 58 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 333 milligram and valproic acid 145 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely valproate sodium 200 milligram and valproic acid 87 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lamotrigine 250 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely alprazolam 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely alprazolam 500 microgram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amisulpride 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely prazosin (as prazosin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely lornoxicam 16 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Existential restriction modifier
12-hour modified-release tablet Is a True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
24-hour modified-release tablet Is a True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Sondate XL 200mg tablets (Teva UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Ebesque XL 200mg tablets (DB Ashbourne Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Psyquet XL 400mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 300mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 400mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 400mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Sondate XL 400mg tablets (Teva UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Tenprolide XL 200mg tablets (Actavis UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Atrolak XL 300mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Atrolak XL 400mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Brancico XL 400mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 200mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seotiapim XL 200mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Tenprolide XL 400mg tablets (Actavis UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Atrolak XL 200mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Biquelle XL 400mg tablets (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Mintreleq XL 300mg tablets (CEB Pharma Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 400mg modified-release tablets (Teva UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seotiapim XL 300mg tablets (Sandoz Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Brancico XL 300mg tablets (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Seroquel XL 300mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier
Sondate XL 300mg tablets (Teva UK Ltd) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 4 of 5 End

This concept is not in any reference sets

Back to Start